Procter & Gamble is still eyeing Pfizer's consumer health unit, but it doesn't like the price: report
admin 3rd April 2018 Uncategorised 0Don’t lose all hope for a Pfizer consumer health sale. Procter & Gamble is still at the negotiating table, CNBC’s David Faber reports, though “it doesn’t appear likely” the two sides will reach an agreement because “they are far apart on price,” he said. Could a separate joint venture come next?
More: Procter & Gamble is still eyeing Pfizer's consumer health unit, but it doesn't like the price: report
Source: fierce